V Guided by V Presented

by
Dr. A.K. Jain Sir Radhika Rao
MBA(HA) 1st sem.
V Definition
V Nanomedicine
V Economic impact of nanotechnology
V Market for Nanomedicine
V Nanotechnology in USA
V Nanotechnology in Developing countries
V Nanotechnology, the
science of studying
and manufacturing
systems at the
nanometer (1
nanometer = 1
billionth of a meter)
level, has the
potential to start a
revolution in
healthcare.
V here are three key areas in which
nanotechnology could revolutionize healthcare:
Diagnosis, Prevention and reatment.

V Most probably, nanotechnology will help medical

professionals in today·s most excruciating
medical issues such as repair of damaged
organs, diagnosis and treatment of cancer
cells, removal of obstructions in the
brain, creation of artificial materials that will
help in diagnosis or delivery of new and better
drugs, creation of artificial tissues etc.
V he demand for nanotechnology medical
products will grow by more than 17 percent
annually to reach $53 billion in 2011 and to
$110 billion in 2016.
V It will account for drug delivery and
biomedical product demand of $3.7 billion in
2009, up from $165 million in 2004.
V he largest share of opportunities will
emerge in pharmaceutical
applications, which are expected to reach
$3.1billion in 2009 and expand to $18 billion
in 2014.
 Demand for
nanotechnology(billion $)
120
110

100

80

60 f r
53
t l (
illi )
40

20

0
2011 2016
V Accordingto U.S. National Science
Foundation estimates, by 2015 the annual
global market for nano-related goods and
services will top $1 trillion, thus making it
one of the fastest-growing industries in
history.
V he total market for nano-medicine will
command strong growth over the long
term, rising to almost $59 billion in 2014 and
sustaining a strong upward pace through
2019.
V reatments based on humanized monoclonal
antibodies, nano-polymers and nano-proteins
will drive gains, with compounds for
cancer, heart diseases, neurological disorders
and viral infections leading new product
introductions and growth opportunities.
Nano-sized monoclonal antibody labels and
DNA probes are greatly enhancing the
speed, accuracy, capabilities and cost-
effectiveness of in vitro diagnostic
testing, drug discovery and medical research
procedures.
Nano-particle formulations of super
paramagnetic iron oxide, gadolinium, per
fluorocarbon and specialty polymers will
broaden in vivo imaging capabilities by
enabling the detection of
tumors, plaque, genetic defects and other
disease states at much earlier stages
V Demand for nanodiagnostics is projected to
increase 6.8 percent per year to $11.3 billion
in 2014, and continue rising at a good pace
through 2019.
V In 2014, demand for medical supplies and
devices based at least partially on nano
materials is projected to reach $5.1
billion, up from $530 million in 2009.

V hisamount will more than triple by 2019 as

nanotechnology-based orthopedic and
cardiac implants and nano coated medical
and surgical instruments penetrate the
marketplace.
 Market value in 2014(in
$billion)

5.1

11.3 Nanomedicine

Nanodiagnostics

Nanotech
materials
59
V Demand for nanotechnology medical
products, including
nanomedicines, nanodiagnostics, and
nanotech-based medical supplies and
devices, will increase over 17 percent per
year to $75.4 billion in 2014.
V More than 5 billion people live in the
developing world who can reap tremendous
health benefits from Nanotechnology.
V Already, Nanotechnology research efforts in
countries such as China, India, Brazil and
South Africa exist that could be tailored to
meet the needs of the poor.
V India has invested $20 million in
Nanotechnology initiatives from 2004-
2009, and Brazil·s budget for 2004-2007 was
about $25 million.
V Nanotechnology has reached critical mass.
Nowhere is this more evident than in
medicine. Rising medical costs, demands for
less-invasive procedures and pressures for
immediate feedback of medical
conditions, all point to nanotechnology as
offering a new approach in healthcare.

V Itpotentially has far-reaching and paradigm-

shifting implications for biology, drug
discovery and medical technologies.
V www.brighthub.com
V www.azonanotechnology.com
V Lux Research
V Freedonia group
V Pubmed central
V Nanotechnology development blog
V National nanotechnology initiative